Looks, on the surface, like a good match of products and market presence – Celgene buys Pharmion. And, in other important oncology news, Nexavar (from Bayer) gets expedited approval for liver cancer.
Also, Schering cleared to take over Organon – by divesting bird vaccines to Wyeth.
Leave a Reply